Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vera

Showing results (201-210 of 204) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 204 results.
Science Translational Medicine|July 31, 2020
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myelomaPremal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancerValentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical EffectsSpyridoula Vasileiou, Premal D Lulla, Ifigeneia Tzannou, et al.
Revista De Gastroenterologia De Mexico (English)|October 8, 2018
Prevalence of eosinophilic esophagitis: A multicenter study on a pediatric population evaluated at thirty-six Latin American gastroenterology centersR Pierre, M Vieira, R Vázquez, et al.
Pageof 21

Showing results (201-210 of 204) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 204 results.
Science Translational Medicine|July 31, 2020
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myelomaPremal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancerValentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2021
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical EffectsSpyridoula Vasileiou, Premal D Lulla, Ifigeneia Tzannou, et al.
Revista De Gastroenterologia De Mexico (English)|October 8, 2018
Prevalence of eosinophilic esophagitis: A multicenter study on a pediatric population evaluated at thirty-six Latin American gastroenterology centersR Pierre, M Vieira, R Vázquez, et al.
Pageof 21